Table 1.
Characteristics of included studies
| Study | Country of publication | Year of publication | Study design | Patient, n | Lesion, n (P/R) | Age (years) | Gender (M:F) | Mean follow-up time (range) |
|---|---|---|---|---|---|---|---|---|
| Kirschniak et al. [16] | Germany | 2011 | Retrospective | 12 | 12 (−/−) | – | – | – |
| Albert et al. [17] | Germany | 2011 | Retrospective | 6 | 6 (2/4) | – | – | At least 1 month (−) |
| Manta et al. [18] | Italy | 2013 | Retrospective | 23 | 23 (0/23) | – | – | At least 1 month (−) |
| Mönkemüller et al. [19] | United States | 2014 | Retrospective | 6 | 6 (0/6) | 72 ± 14.5 | 4:2 | – |
| Chan et al. [11] | China | 2014 | Prospective | 9 | 9 (3/6) | 72.5 (39–89) | 4:5 | – |
| Skinner et al. [12] | United States | 2014 | Retrospective | 12 | 12 (0/12) | 59 (29–86) | 8:4 | At least 1 month (−) |
| Manno et al. [20] | Italy | 2016 | Retrospective | 40 | 40 (40/0) | 69 (25–94) | 33:7 | At least 1 month (−) |
| Wedi et al. [21] | France | 2016 | Retrospective | 41 | 41 (13/28) | – | – | – |
| Richter-Schrag et al. [22] | Germany | 2016 | Retrospective | 63 | 69 (39/30) | 68 (27–92) | 38:25 | – |
| Lamberts et al. [23] | Germany | 2017 | Retrospective | 68 | 68 (−/−) | – | – | – |
| Goenka et al. [24] | India | 2017 | Prospective | 6 | 6 (0/6) | 62 ± 13.1 | 5:1 | At least 1 month (1–1.4) |
| Wedi et al. [25] | Germany | 2017 | Retrospective | 118 | 120 (120/0) | 71 ± 12.4 | – | – |
| Schmidt et al. [26] | Germany | 2018 | Prospective randomized trial | 33 | 33 (0/33) | 77 (33–90) | 20:13 | At least 1 month (−) |
| Asokkumar et al. [27] | Singapore | 2018 | Retrospective | 18 | 19 (10/9) | 68 ± 15.9 (22–91) | 12:6 | At least 1 month (−) |
| Manta et al. [13] | Italy | 2018 | Retrospective | 214 | 214 (214/0) | 66 ± 10.2 | 115:99 | At least 1 month (−) |
| Gölder et al. [28] | Germany | 2019 | Retrospective | 100 | 100 (66/34) | 76 (20–98) | 64:36 | – |
M:F male to female, P primary treatment, R rescue treatment